10x Genomics and Harvard University sued Element Biosciences over alleged infringement tied to Element’s AVITI24 multiomics platform and related workflows. The complaint asserts infringement of four Harvard-owned patents, including patents covering methods for analyzing nucleic acids and selective sequencing of amplicons. 10x and Harvard requested findings of willful infringement, declarations of patent validity and enforceability, and injunctive relief or post-judgment royalties and attorneys’ fees. Element denied the allegations and said it will fight the case. The lawsuit underscores how spatial biology and multiomics platform expansion is now paired with patent enforcement actions—potentially affecting instrument availability, workflow deployment, and customer procurement timelines in targeted research areas.